Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Acquisitions & Divestments: 2017-2024

Historic Change in Acquisitions & Divestments for Anaptysbio (ANAB) over the last 8 years, with Dec 2024 value amounting to $476.1 million.

  • Anaptysbio's Change in Acquisitions & Divestments rose 11.77% to $123.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $442.8 million, marking a year-over-year decrease of 11.47%. This contributed to the annual value of $476.1 million for FY2024, which is 5.93% up from last year.
  • As of FY2024, Anaptysbio's Change in Acquisitions & Divestments stood at $476.1 million, which was up 5.93% from $449.5 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's Change in Acquisitions & Divestments registered a high of $476.1 million during FY2024, and its lowest value of $158.8 million during FY2021.
  • For the 3-year period, Anaptysbio's Change in Acquisitions & Divestments averaged around $444.5 million, with its median value being $449.5 million (2023).
  • In the last 5 years, Anaptysbio's Change in Acquisitions & Divestments tumbled by 45.22% in 2021 and then skyrocketed by 156.86% in 2022.
  • Yearly analysis of 5 years shows Anaptysbio's Change in Acquisitions & Divestments stood at $290.0 million in 2020, then crashed by 45.22% to $158.8 million in 2021, then spiked by 156.86% to $408.0 million in 2022, then increased by 10.16% to $449.5 million in 2023, then grew by 5.93% to $476.1 million in 2024.